Skip to main navigation
Skip to search
Skip to main content
University of Kentucky Home
LOGIN & Help
Link opens in a new tab
English
EspaƱol
Search content at University of Kentucky
Home
Research units
Researchers
Projects & Grants
Research Output
Facilities & Equipment
Honors & Awards
Activities
Understanding the role of anti-apolipoprotein A-I antibodies in atherosclerotic cardiovascular disease
Venditto, Vincent
(PI)
Daugherty, Alan
(CoI)
Temel, Ryan
(CoI)
Charnigo, Richard
(Former CoI)
Pharmaceutical Sciences
Saha Cardiovascular Research Center (CVRC)
Cardiovascular Research Priority Area
Overview
Fingerprint
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Immunology and Microbiology
Apolipoprotein
100%
Cardiovascular System
100%
Epitope
40%
Atherosclerosis
40%
Immune Response
20%
Antibody Response
20%
Antigen
20%
B Cell
10%
Mouse Model
10%
Immunomodulation
10%
Cell Interaction
10%
Autoantigen
10%
Antiinflammatory Activity
10%
Immunoglobulin G Antibody
10%
Antibody Specificity
10%
Fc Receptor
10%
High-Density Lipoprotein
10%
Homo sapiens
10%
Therapeutic Target
10%
Pharmacology, Toxicology and Pharmaceutical Science
Coronary Artery Atherosclerosis
100%
Apolipoprotein A
100%
Epitope
40%
Atherosclerosis
40%
Disease Exacerbation
20%
Antigen
20%
Diseases
10%
Receptor
10%
Autoantigen
10%
High Density Lipoprotein
10%
Fc Receptor
10%
Antiinflammatory Activity
10%
Mouse Model
10%
Atherosclerotic Plaque
10%
Homo sapiens
10%
Immunoglobulin G Antibody
10%
Immunomodulation
10%